Global Bioinformatics Services Market Size Study, By Type, By Application, By Sector, and Regional Forecasts 2022-2032

Description

The global bioinformatics services market was valued at approximately USD 2.8 billion in 2023 and is anticipated to witness a robust CAGR of 14.46% from 2024 to 2032. With the rising adoption of next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML) algorithms, bioinformatics is revolutionizing multiple industries, including pharmaceuticals, biotechnology, and clinical research. The growing demand for personalized medicine, drug discovery, and genomics research has significantly fueled investments in bioinformatics services, making it an indispensable tool for genetic data analysis and molecular modeling.

The integration of AI-driven bioinformatics platforms has transformed how data is processed, analyzed, and interpreted in medical research and precision medicine. Cloud-based bioinformatics services have further propelled market growth by offering scalable, flexible, and cost-efficient solutions for large-scale genomic data analysis. The rising prevalence of chronic diseases such as cancer and cardiovascular disorders has also led to an increased demand for bioinformatics-driven drug discovery, enhancing the industry's expansion. Additionally, government-backed initiatives in genomics, combined with strategic collaborations between biotech firms, pharmaceutical companies, and research institutions, continue to strengthen the market's global presence.

The expansion of bioinformatics services in emerging markets such as Asia Pacific, Latin America, and the Middle East & Africa is accelerating due to rising genomics investments and biotech advancements. Countries such as China, India, and Japan are heavily investing in biotechnology, supported by government funding and research initiatives. Meanwhile, North America remains a dominant player, with leading bioinformatics firms, research institutions, and pharmaceutical giants leveraging bioinformatics tools for advanced drug discovery, precision medicine, and agricultural genomics.

Major market players included in this report are:

Agilent Technologies, Inc.
BGI Group
Dotmatics
Labvantage - Biomax GmbH
CD Genomics
Creative Biolabs
DNAnexus, Inc.
DNASTAR
Fios Genomics
Illumina, Inc.
PerkinElmer Inc.
QIAGEN
Thermo Fisher Scientific Inc.
SOPHiA GENETICS
Strand Life Sciences

The detailed segments and sub-segments of the market are explained below:

By Type

Next-Generation Sequencing (NGS)
- Targeted Sequencing Analysis
- Transcriptome Analysis
- Whole Genome
- Chip Seq Analysis
- De novo Assembly
- Methyl Seq Analysis
Chemoinformatics
- Sequence Analysis Platforms
- Molecular Modeling
- Docking
- Clinical Trial Data Management
- Others
Microarray Data Analysis
Biological Data Curation
Scientific Software Testing
Other Services

By Application

Genomics
Transcriptomics
Proteomics
Metabolomics
Drug Discovery
Others

By Sector

Medical
Animal
Agricultural
Academics

By Region

North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait

Years considered for the study:

Historical Year: 2022
Base Year: 2023
Forecast Period: 2024-2032

Key Takeaways:

Market estimates and forecasts for 10 years (2022-2032).
Annualized revenues and regional-level analysis for each market segment.
Detailed competitive landscape analysis.
Insights into key industry trends and future market opportunities.
Demand-side and supply-side analysis of the bioinformatics services market.
Coverage of regulatory frameworks, data security standards, and privacy laws affecting the market.

Chapter 1. Global Bioinformatics Services Market Executive Summary

1.1. Global Bioinformatics Services Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Type
- 1.3.2. By Application
- 1.3.3. By Sector
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Bioinformatics Services Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Bioinformatics Services Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising Demand for Bioinformatics in Drug Discovery & Development
- 3.1.2. Growing Adoption of AI and Machine Learning in Bioinformatics
- 3.1.3. Increasing Investment in Genomics Research and Personalized Medicine
3.2. Market Challenges
- 3.2.1. High Costs Associated with Bioinformatics Services
- 3.2.2. Complexity of Data Integration and Standardization
3.3. Market Opportunities
- 3.3.1. Expansion of Cloud-Based Bioinformatics Solutions
- 3.3.2. Growing Applications of Bioinformatics in Agriculture & Animal Genomics
- 3.3.3. Rising Government Initiatives Supporting Genomics and Biotechnology

Chapter 4. Global Bioinformatics Services Market Industry Analysis

4.1. Porter's Five Forces Analysis
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Bioinformatics Services Market Size & Forecasts by Type (2022-2032)

5.1. Segment Dashboard
5.2. Global Bioinformatics Services Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 5.2.1. NGS
  - 5.2.1.1. Targeted Sequencing Analysis
  - 5.2.1.2. Transcriptome Analysis
  - 5.2.1.3. Whole Genome
  - 5.2.1.4. Chip Seq Analysis
  - 5.2.1.5. De novo Assembly
  - 5.2.1.6. Methyl Seq Analysis
- 5.2.2. Chemoinformatics
  - 5.2.2.1. Sequence Analysis Platforms
  - 5.2.2.2. Molecular Modeling
  - 5.2.2.3. Docking
  - 5.2.2.4. Clinical Trial Data Management
- 5.2.3. Microarray Data Analysis
- 5.2.4. Biological Data Curation
- 5.2.5. Scientific Software Testing
- 5.2.6. Other Services

Chapter 6. Global Bioinformatics Services Market Size & Forecasts by Application (2022-2032)

6.1. Segment Dashboard
6.2. Global Bioinformatics Services Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 6.2.1. Genomics
- 6.2.2. Transcriptomics
- 6.2.3. Proteomics
- 6.2.4. Metabolomics
- 6.2.5. Drug Discovery
- 6.2.6. Others

Chapter 7. Global Bioinformatics Services Market Size & Forecasts by Sector (2022-2032)

7.1. Segment Dashboard
7.2. Global Bioinformatics Services Market: Sector Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 7.2.1. Medical
- 7.2.2. Animal
- 7.2.3. Agricultural
- 7.2.4. Academics

Chapter 8. Global Bioinformatics Services Market Size & Forecasts by Region (2022-2032)

8.1. North America Bioinformatics Services Market
- 8.1.1. U.S.
- 8.1.2. Canada
- 8.1.3. Mexico
8.2. Europe Bioinformatics Services Market
- 8.2.1. UK
- 8.2.2. Germany
- 8.2.3. France
- 8.2.4. Italy
- 8.2.5. Spain
- 8.2.6. Denmark
- 8.2.7. Sweden
- 8.2.8. Norway
8.3. Asia-Pacific Bioinformatics Services Market
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. India
- 8.3.4. Australia
- 8.3.5. South Korea
- 8.3.6. Thailand
8.4. Latin America Bioinformatics Services Market
- 8.4.1. Brazil
- 8.4.2. Argentina
8.5. Middle East & Africa (MEA) Bioinformatics Services Market
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. South Africa
- 8.5.4. Kuwait

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Agilent Technologies, Inc.
- 9.1.2. Illumina, Inc.
- 9.1.3. Thermo Fisher Scientific Inc.
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. BGI Group
- 9.3.2. Dotmatics
- 9.3.3. Labvantage - Biomax GmbH
- 9.3.4. CD Genomics
- 9.3.5. Creative Biolabs
- 9.3.6. DNAnexus, Inc.
- 9.3.7. DNASTAR
- 9.3.8. Fios Genomics
- 9.3.9. PerkinElmer Inc.
- 9.3.10. QIAGEN

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes